Abstract:As a result of surgical trauma, ischemia and exposure to arterial pressure the majority of endothelium in vein grafts (VG) undergo necrosis or apoptosis. We hypothesized that increased eNOS coupling could protect endothelial viability after VG surgery. To investigate this we utilized a transgenic mouse with endothelial-targeted overexpression of the essential eNOS coupling cofactor BH4. We investigated the effect of BH4 on endothelial cell survival and vascular remodeling in vitro and in vivo using ApoE-KO mice with endothelial-targeted overexpression of the rate limiting enzyme of BH4 synthesis GTP cyclohydrolase 1 (GCH) and LacZ reporter gene. BH4 levels were increased 10-fold in primary endothelium and 5-fold in aorta from GCH/ApoE-KO mice compared with ApoE-KO, without concomitant increases in eNOS protein. Despite no differences at baseline, following 4 days of culture, total endothelial cell number, colony size and number from GCH/ApoE-KO mice were increased (5-fold P=0.05; 2-fold P=0.02; 2-fold P=0.06 respectively, n=6) as were putative EPC levels from bone-marrow mononuclear cells determined by culture (15%,P=0.04) and FACS (26%, P=0.03). Vascular injury as a result of VG surgery in ApoE-KO mice led to significant neointima that was augmented by 61% (P=0.002) in GCH/ApoE-KO mice. Furthermore, endothelial repopulation was accelerated by 21% (P=0.01) and endothelial survival 44% (P=0.03) in these animals. O2- production was significantly attenuated in GCH/ApoE-KO mice measured on both aortic sections using oxidative microtopography and whole aorta by lucigenin chemiluminescence. eNOS inhibition by L-NAME reversed these effects indicating that under basal conditions GCH/ApoE-KO mice had preserved eNOS coupling promoting NO synthesis. In keeping with these findings in 219 patients with coronary artery disease, analysis of saphenous vein and internal mammary artery identified that high vascular BH4 levels were associated with greater vasorelaxations to acetylcholine (P<0.05) and reduced total L-NAME inhibitable O2- suggesting improved eNOS coupling. Availability of BH4 within the endothelium critically modulates the response to vascular injury by maintaining eNOS coupling and accelerating endothelial regeneration.

Endothelial Nitric Oxide Synthase Enhancer AVE3085 Reverses Endothelial Dysfunction Induced by Homocysteine in Human Internal Mammary Arteries

Effects of Astragalus Membranaceus and Its Main Components on the Acute Phase Endothelial Dysfunction Induced by Homocysteine

New Strategy of Endothelial Protection in Cardiac Surgery: Use of Enhancer of Endothelial Nitric Oxide Synthase

Interference in mevalonate pathway ameliorates homocysteine-induced endothelium-dysfunction.

Homocysteine Causes Endothelial Dysfunction via Inflammatory Factor-Mediated Activation of Epithelial Sodium Channel (ENaC)

Homocysteine Reduces Protein S-Nitrosylation in Endothelium

Endothelial Scaffolding Protein ENH (Enigma Homolog Protein) Promotes PHLPP2 (Pleckstrin Homology Domain and Leucine-Rich Repeat Protein Phosphatase 2)-Mediated Dephosphorylation of AKT1 and eNOS (Endothelial NO Synthase) Promoting Vascular Remodeling.

Homocysteine Impairs Coronary Artery Endothelial Function by Uncoupling Endothelial Nitric Oxide Synthase in Patients with Hyperhomocysteinemia

Heme oxygenase-1 ameliorates oxidative stress-induced endothelial senescence via regulating endothelial nitric oxide synthase activation and coupling

Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine

Abstract 18700: Accelerated Endothelial Regeneration and Survival Attenuate Vein Graft Atherosclerosis via Terahydrobiopterin-Dependent eNOS Coupling

Homocysteine ameliorates the endothelium-independent hypoxic vasoconstriction via the suppression of phosphatidylinositol 3-kinase/Akt pathway in porcine coronary arteries

Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.

Hypercysteinemia promotes atherosclerosis by reducing protein S-nitrosylation.

Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation

Traditional Chinese medicine xin-mai-jia recouples endothelial nitric oxide synthase to prevent atherosclerosis in vivo

Atorvastatin Inhibits Homocysteine-Induced Dysfunction and Apoptosis in Endothelial Progenitor Cells.

Docosahexaenoic Acid Alleviates Trimethylamine-N-oxide-mediated Impairment of Neovascularization in Human Endothelial Progenitor Cells

Naringenin ameliorates homocysteine induced endothelial damage via the AMPKα/Sirt1 pathway

Emodin protects against homocysteine-induced cardiac dysfunction by inhibiting oxidative stress via MAPK and Akt/eNOS/NO signaling pathways

Homoarginine Supplementation Prevents Left Ventricular Dilatation and Preserves Systolic Function in a Model of Coronary Artery Disease.